FIELD: biotechnology.
SUBSTANCE: invention relates to production of full-length fragments of the eye lens epithelial growth factor (LEDGF), and can be used in medicine. LEDGF fragment with SEQ ID NO: 2 is obtained, which is used in pharmaceutical compositions for treatment of diseases associated with protein aggregation.
EFFECT: invention can effectively treat diseases associated with protein aggregation, in particular ocular diseases.
15 cl, 31 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS FOR PROTEIN DELIVERY AND METHODS OF THEIR APPLICATION | 2008 |
|
RU2526904C2 |
| PEPTIDES FOR INHIBITING ANGIOGENESIS | 2016 |
|
RU2708375C2 |
| ANTI-C5a ANTIBODIES AND THEIR APPLICATIONS | 2018 |
|
RU2773779C2 |
| COMPOSITIONS AND METHODS FOR DRUG DELIVERY | 2009 |
|
RU2496482C2 |
| PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 | 2008 |
|
RU2488592C2 |
| SELECTIVE R-CADHERIN ANTAGONISTS AND METHODS | 2004 |
|
RU2349598C2 |
| INORGANIC PYROPHOSPHATE AND ITS APPLICATION | 2012 |
|
RU2626932C2 |
| VECTORS ENCODING ROD-DERIVED CONE VIABILITY FACTOR | 2012 |
|
RU2664673C2 |
| CYTOMEGALOVIRUS VACCINE AND METHOD FOR PREPARING IT | 2008 |
|
RU2491340C2 |
| COMPOSITIONS AND METHODS OF TREATING MPS1 | 2014 |
|
RU2708318C2 |
